Chronic thromboembolic pulmonary hypertension (CTEPH) is a rare and progressive form of pulmonary hypertension (PH) caused by blood clots that don’t dissolve in the lungs. These clots cause scar-like tissue that clogs up or narrows the small blood vessels in the lungs. The characteristics and challenges of diagnosing CTPEH are discussed in this touchRESPIRATORY interview with Dr Gustavo Heresi (Cleveland Clinic, Cleveland, OH, USA) as well as what can be done to overcome these diagnostic challenges.
The presentation titled ‘CTEPH – Overview and Treatments’ was presented at the Pulmonary Hypertension Association, June 10-12, 2022
Questions
- What are the characteristic features of chronic thromboembolic pulmonary hypertension (CTEPH) and how does it differ from other forms of PH?
- What are the challenges of diagnosing CTPEH and how can they be overcome?
Disclosures: Gustavo Heresi discloses grant/research support from Bayer Healthcare.
Support: Interview and filming supported by Touch Medical Media Ltd. Interview conducted by Shanice Allen.
Filmed in coverage of the PHA Hybrid Congress 2022.
